Relief Therapeutics controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Aviptadil collaboration lawsuit
Relief Therapeutics filed a lawsuit in New York against NRx Pharmaceuticals and its chief executive Jonathan Javitt, alleging multiple breaches of the companies' agreement concerning the co-development of aviptadil. The allegations were part of a commercial dispute and are not presented here as established findings of wrongdoing.